Characterization of Hypervirulent Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Among Urinary Tract Infections: The First Report from Iran

References

• Melot B, Colot J, Guerrier G. Bacteremic community-acquired infections due to Klebsiella pneumoniae: clinical and microbiological presentation in New Caledonia, 2008–2013. Int J Infect Dis. 2015;41:29–31. doi:10.1016/j.ijid.2015.10.01326518064
   PubMed Web of Science ®Google Scholar
• Ghanavati R, Darban-Sarokhalil D, Navab-Moghadam F, Kazemian H, Irajian G, Razavi S. First report of coexistence of AmpC beta-lactamase genes in Klebsiella pneumoniae strains isolated from burn patients. Acta Microbiol Immunol Hung. 2017;64(4):455–462. doi:10.1556/030.64.2017.02828859497
   PubMed Web of Science ®Google Scholar
• Shrivastava SR, Shrivastava PS, Ramasamy J. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. J Med Soc. 2018;32(1):76.
   Google Scholar
• Lin W-H, Wang M-C, Tseng -C-C, et al. Clinical and microbiological characteristics of Klebsiella pneumoniae isolates causing community-acquired urinary tract infections. Infection. 2010;38(6):459–464.20734217
   PubMed Web of Science ®Google Scholar
• Prokesch BC, TeKippe M, Kim J, Raj P, TeKippe EM, Greenberg DE. Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect Dis. 2016;16(9):e190–e5. doi:10.1016/S1473-3099(16)30021-427402393
   PubMedGoogle Scholar
• Liu C, Guo J. Hypervirulent Klebsiella pneumoniae (hypermucoviscous and aerobactin positive) infection over 6 years in the elderly in China: antimicrobial resistance patterns, molecular epidemiology and risk factor. Ann Clin Microbiol Antimicrob. 2019;18(1):4. doi:10.1186/s12941-018-0302-930665418
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng J, Liu W, et al. Emergence of a hypervirulent carbapenem-resistant Klebsiella pneumoniae isolate from clinical infections in China. J Infect. 2015;71(5):553–560.26304687
   PubMed Web of Science ®Google Scholar
• Zhan L, Wang S, Guo Y, et al. Outbreak by hypermucoviscous Klebsiella pneumoniae ST11 isolates with carbapenem resistance in a tertiary hospital in China. Front Cell Infect Microbiol. 2017;7:182.28560183
   PubMed Web of Science ®Google Scholar
• Patel PK, Russo TA, Karchmer AW, editors. Hypervirulent Klebsiella pneumoniae In: Open Forum Infectious Diseases. Oxford University Press; 2014.
   Google Scholar
• Liu YM, Zhang YY, Zhang W, Shen H, Li H, Cao B. Clinical and molecular characteristics of emerging hypervirulent Klebsiella pneumoniae bloodstream infections in mainland China. Antimicrob Agents Chemother. 2014;58:5379–5385. doi:10.1128/AAC.02523-1424982067
   PubMed Web of Science ®Google Scholar
• Ye M, Tu J, Jiang J, et al. Clinical and genomic analysis of liver abscess-causing Klebsiella pneumoniae identifies new liver abscess-associated virulence genes. Front Cell Infect Microbiol. 2016;6(165). doi:10.3389/fcimb.2016.00165
   Web of Science ®Google Scholar
• Zhao Y, Zhang X, Torres VL, et al. An outbreak of carbapenem-resistant and hypervirulent Klebsiella pneumoniae in an intensive care unit of a major teaching hospital in Wenzhou, China. Front Public Health. 2019;7:229.31552210
   PubMed Web of Science ®Google Scholar
• Bajaj P, Singh NS, Virdi JS. Escherichia coli β-lactamases: what really matters. Front Microbiol. 2016;7:417.27065978
   PubMed Web of Science ®Google Scholar
• Ni Q, Tian Y, Zhang L, et al. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China. Diagn Microbiol Infect Dis. 2016;86(4):428–433.27681363
   PubMed Web of Science ®Google Scholar
• Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin Microbiol Rev. 2009;22(4):664–689.19822894
   PubMed Web of Science ®Google Scholar
• García-Fulgueiras V, Bado I, Mota MI, et al. Extended-spectrum β-lactamases and plasmid-mediated quinolone resistance in enterobacterial clinical isolates in the paediatric hospital of Uruguay. J Antimicrob Chemother. 2011;66(8):1725–1729. doi:10.1093/jac/dkr22221685201
   PubMed Web of Science ®Google Scholar
• Rodríguez-Martínez JM, Velasco C, Pascual Á, Cano ME. Plasmid-mediated quinolone resistance: an update. J Infect Chemother. 2011;17(2):149–182. doi:10.1007/s10156-010-0120-220886256
   PubMed Web of Science ®Google Scholar
• Magiorakos A-P, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.21793988
   PubMed Web of Science ®Google Scholar
• Mansouri S, Abbasi S. Prevalence of multiple drug resistant clinical isolates of extended-spectrum beta-lactamase producing Enterobacteriaceae in Southeast Iran. Iran J Med Sci. 2015;35(2):101–108.
   Google Scholar
• Di Tella D, Tamburro M, Guerrizio G, et al. Molecular epidemiological insights into Colistin-resistant and Carbapenemases-producing clinical Klebsiella pneumoniae isolates. Infect Drug Resist. 2019;12:3783.31819559
   PubMed Web of Science ®Google Scholar
• Liu X, Liu H, Wang L, et al. Molecular characterization of extended-spectrum β-lactamase-producing multidrug resistant Escherichia coli from swine in Northwest China. Front Microbiol. 2018;9:1756.30123199
   PubMed Web of Science ®Google Scholar
• CDC/HICPAC. Urinary Tract Infection (UTI) Event for Long- Term Care Facilities. Atlanta, GA, USA: CDC; 2009.
   Google Scholar
• Sathiananthamoorthy S, Malone-Lee J, Gill K, et al. Reassessment of routine midstream culture in diagnosis of urinary tract infection. J Clin Microbiol. 2019;57(3):e01452–18.30541935
   PubMed Web of Science ®Google Scholar
• Cubero M, Marti S, MÁ D, González-Díaz A, Berbel D, Ardanuy C. Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface. PLoS One. 2019;14(9):e0222628.31532800
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute. 2019 Performance standards for antimicrobial susceptibility testing; Twentynineth informational supplement CdM-SCaLSI, Wayne, PA.
   Google Scholar
• Shoja S, Ansari M, Faridi F, et al. Identification of carbapenem-resistant Klebsiella pneumoniae with emphasis on New Delhi metallo-beta-lactamase-1 (bla NDM-1) in Bandar Abbas, South of Iran. Microb Drug Resist. 2018;24(4):447–454.28972857
   PubMed Web of Science ®Google Scholar
• Rajivgandhi G, Maruthupandy M, Veeramani T, Quero F, Li WJ. Anti-ESBL investigation of chitosan/silver nanocomposites against carbapenem resistant Pseudomonas aeruginosa. Int J Biol Macromol. 2019;132:1221–1234.30946905
   PubMed Web of Science ®Google Scholar
• Rajivgandhi G, Maruthupandy M, Ramachandran G, Priyanga M, Manoharan N. Detection of ESBL genes from ciprofloxacin resistant Gram negative bacteria isolated from urinary tract infections (UTIs). Front Lab Med. 2018;2(1):5–13.
   Google Scholar
• Rajivgandhi G, Vijayan R, Maruthupandy M, Vaseeharan B, Manoharan N. Antibiofilm effect of Nocardiopsis sp. GRG 1 (KT235640) compound against biofilm forming Gram negative bacteria on UTIs. Microb Pathog. 2018;118:190–198.29524549
   PubMed Web of Science ®Google Scholar
• Rajivgandhi G, Ramachandran G, Maruthupandy M, Senthil R, Vaseeharan B, Manoharan N. Molecular characterization and antibacterial investigation of marine endophytic actinomycetes Nocardiopsis sp. GRG 2 (KT 235641) compound against isolated ESBL producing bacteria. Microb Pathog. 2018.
   Web of Science ®Google Scholar
• Rajivgandhi G, Maruthupandy M, Muneeswaran T, et al. Biologically synthesized copper oxide nanoparticles enhanced intracellular damage in ciprofloxacin resistant ESBL producing bacteria. Microb Pathog. 2019;127:267–276.30550842
   PubMed Web of Science ®Google Scholar
• Maruthupandy M, Muneeswaran T, Song J-M, Manoharan N. Biologically synthesized zinc oxide nanoparticles as nanoantibiotics against ESBLs producing gram negative bacteria. Microb Pathog. 2018;121:224–231. doi:10.1016/j.micpath.2018.05.04129807135
   PubMed Web of Science ®Google Scholar
• Halaji M, Shahidi S, Atapour A, et al. Characterization of extended-spectrum β-lactamase-producing uropathogenic Escherichia coli among Iranian kidney transplant patients. Infect Drug Resist. 2020;13:1429.32523361
   PubMed Web of Science ®Google Scholar
• Chen W-P, Kuo -T-T. A simple and rapid method for the preparation of gram-negative bacterial genomic DNA. Nucleic Acids Res. 1993;21(9):2260.8502576
   PubMed Web of Science ®Google Scholar
• Rajivgandhi G, Maruthupandy M, Manoharan N. Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs). Microb Pathog. 2018;121:123–130.29778819
   PubMed Web of Science ®Google Scholar
• Dallenne C, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65(3):490–495. doi:10.1093/jac/dkp49820071363
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang W, Pan W, et al. Prevalence of qnr, aac(6′)-Ib-cr, qepA, and oqxAB in Escherichia coli isolates from humans, animals, and the environment. Antimicrob Agents Chemother. 2012;56(6):3423–3427. doi:10.1128/AAC.06191-1122391545
   PubMed Web of Science ®Google Scholar
• Lee C-H, Chuah S-K, Tai W-C, Chang -C-C, Chen F-J. Delay in human neutrophil constitutive apoptosis after infection with Klebsiella pneumoniae serotype K1. Front Cell Infect Microbiol. 2017;7:87.28396849
   PubMed Web of Science ®Google Scholar
• Stamm WE, Hooton TM, Johnson JR, et al. Urinary tract infections: from pathogenesis to treatment. J Infect Dis. 1989;159(3):400–406.2644378
   PubMed Web of Science ®Google Scholar
• Li W, Sun G, Yu Y, et al. Increasing occurrence of antimicrobial-resistant hypervirulent (hypermucoviscous) Klebsiella pneumoniae isolates in China. Clin Infect Dis. 2014;58(2):225–232.24099919
   PubMed Web of Science ®Google Scholar
• Zhang R, Lin D, Chan EW-C, et al. Emergence of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae strains in China. Antimicrob Agents Chemother. 2016;60(1):709–711.26574010
   PubMed Web of Science ®Google Scholar
• Ripabelli G, Sammarco ML, Scutellà M, Felice V, Tamburro M. Carbapenem-resistant KPC-and TEM-producing Escherichia coli ST131 isolated from a hospitalized patient with urinary tract infection: first isolation in Molise region, Central Italy, July 2018. Microb Drug Resist. 2020;26(1):38–45.31386590
   PubMed Web of Science ®Google Scholar
• Kao C-Y, Udval U, Huang Y-T, et al. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia. J Microbiol Immunol Infect. 2016;49(5):692–700.26194952
   PubMedGoogle Scholar
• Yang Y-S, Ku C-H, Lin J-C, et al. Impact of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the outcome of community-onset bacteremic urinary tract infections. J Microbiol Immunol Infect. 2010;43(3):194–199.21291846
   PubMedGoogle Scholar
• Koksal E, Tulek N, Sonmezer MC, et al. Investigation of risk factors for community-acquired urinary tract infections caused by extended-spectrum beta-lactamase Escherichia coli and Klebsiella species. Investig Clin Urol. 2019;60(1):46–53.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhao C, Wang Q, et al. High prevalence of hypervirulent klebsiella pneumoniae infection in china: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob Agents Chemother. 2016;60:6115–6120. doi:10.1128/AAC.01127-1627480857
   PubMed Web of Science ®Google Scholar
• Lin J-C, Chang F-Y, Fung C-P, et al. High prevalence of phagocytic-resistant capsular serotypes of Klebsiella pneumoniae in liver abscess. Microbes Infect. 2004;6(13):1191–1198.15488738
   PubMed Web of Science ®Google Scholar
• Russo TA, Olson R, Fang C-T, et al. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J Clin Microbiol. 2018;56(9):e00776–18.29925642
   PubMed Web of Science ®Google Scholar
• Pishtiwan AH, Khadija KM. Prevalence of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing Klebsiella pneumoniae and Escherichia coli isolated from thalassemia patients in Erbil, Iraq. Mediterr J Hematol Infect Dis. 2019;11(1).
   Google Scholar
• Yadav KK, Khadka R, Pant AD, Shah B. Multidrug resistant Enterobacteriaceae and extended spectrum beta-lactamase producing Escherichia coli: a cross-sectional study in National Kidney Center, Nepal. Antimicrob Resist Infect Control. 2015;4:42.26504518
   PubMed Web of Science ®Google Scholar
• Lu P-L, Liu Y-C, Toh H-S, et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the study for monitoring antimicrobial resistance trends. Int J Antimicrob Agents. 2012;40:S37–S43. doi:10.1016/S0924-8579(12)70008-022749057
   PubMed Web of Science ®Google Scholar
• Izadi N, Nasab MN, Mood EH, Meshkat Z. The frequency of qnr genes in extended-spectrum β-lactamases and non-ESBLs Klebsiella pneumoniae species isolated from patients in Mashhad, Iran. Iran J Pathol. 2017;12(4):377.29563934
   PubMedGoogle Scholar
• Salah FD, Soubeiga ST, Ouattara AK, et al. Distribution of quinolone resistance gene (qnr) in ESBL-producing Escherichia coli and Klebsiella spp. in Lomé, Togo. Antimicrob Resist Infect Control. 2019;8(1):104.31244995
   PubMed Web of Science ®Google Scholar
• Jamali L, Haouzane F, Bouchajou M. Prevalence of plasmid mediated quinolone resistance genes among enterobacteria isolates in Moroccan community. Int J Innov Sci Res J. 2014;11:387–399.
   Google Scholar
• Jacoby G, Strahilevitz J, Hooper D. Plasmid-mediated quinolone resistance. Microbiol Spectr. 2014;2. doi:10.1128/microbiolspec.PLAS-0006-2013
   Google Scholar